indianstockmarket
Home Results Stocks to Buy About Us Contact Us
 
indianstockmarket
 
ABB Limited
ACC Limited
Bajaj Auto Ltd
Bharti Airtel Limited
Bharat Heavy Electricals Ltd
Cipla Ltd
Dabur India Ltd
Dr. Reddy's Laboratories
GAIL (India) Limited
GlaxoSmithKline Ltd
Grasim Industries Ltd
Gujarat Ambuja Cement Ltd
HCL Technologies Ltd
H D F C
HDFC Bank Ltd
Hero Honda Motors Ltd
Hindalco Industries Ltd
Hindustan Lever Ltd
H P C L
ICICI Bank Ltd
Infosys Technologies Ltd
I P C L
I T C Ltd
Jet Airways (India) Ltd
Larsen & Toubro Limited
Mahindra & Mahindra Ltd
Maruti Udyog Limited
M T N L
N A L C O
Oil & Natural Gas Corpn Ltd
Oriental Bank of Commerce
Punjab National Bank
Ranbaxy Laboratories Ltd
Reliance Communications
Reliance Energy Ltd
Reliance Industries Ltd
Steel Authority of India Ltd
Satyam Computer Services
State Bank of India
Siemens Ltd
Sun Pharmaceuticals
Suzlon Energy Ltd
Tata Motors Limited
Tata Power Co. Ltd
Tata Steel Limited
Tata Consultancy Services
V S N L
Wipro Ltd
Zee Telefilms Ltd
 
http://mumbaibull.com
 
http://winfromus.com
 

Indian Stock Market

Indianstockmarket.net is an effort to educate indian investor by providing useful stock news, stock market websites, informative articles, resources to various investment guides.
Yahoo   Google
Sun, 11 May 2008 21:46:59 GMT

Antibiotics rule pharma retail market (The Times of India)
The first quarter (January-March) of this year has witnessed a change in the domestic pharma retail market with antibiotics and anti-bacterial drugs dominating the show in top 10 brands.
Sun, 04 May 2008 16:18:16 GMT

Sensex firms see worst profit growth in 2 yrs (Hindustan Times)
Companies that are part of the Sensex have seen their worst profit growth in eight quarters during the three-month period ended on 31 March, according to an analysis of figures released by 22 firms that are part of the 30-stock benchmark index of the Bombay Stock Exchange.
Mon, 28 Apr 2008 19:38:35 GMT

Cipla (Rs 215.15): Sell (The Hindu)
We recommend a sell in Cipla from a short-term perspective. From the charts of Cipla, we see that the stock had been on medium-term uptrend from its January 2008 low of Rs 161, till it encountered resistance at around Rs 230 level recently.
Fri, 25 Apr 2008 20:59:58 GMT

Cipla FY08 net up 4.8%, Andhra Bank net down (Express India)
Pharma major Cipla Ltd has posted a net profit-after-tax of Rs 700.48 crore for the year ended March 31, 2008 as compared to Rs 668.03 crore for the year ended March 31, 2007, an increase of just 4.8%.
Fri, 25 Apr 2008 18:10:18 GMT

Robust sales drive Cipla Q4 net up 43% (The Hindu)
Mumbai, April 25 Cipla Ltd has posted a 43 per cent growth in net profit for the three months ended March 31, 2008, on the back of robust exports and increased domestic sales.
Fri, 25 Apr 2008 12:53:51 GMT

Cipla net surges by 43% in Q4 (PharmaBiz)
Cipla Ltd, a US $1 billion pharmaceutical company from Mumbai, has achieved strong net profit growth during the fourth quarter ended March 2008 despite rupee appreciation.
Fri, 25 Apr 2008 12:00:40 GMT

Cipla Q4 net jumps 42.8% y-o-y (Business Standard India)
Pharmaceutical major Cipla Ltd has posted a jump of 42.8 per cent jump in net profit after tax at Rs 179.5 crore for the quarter ended March 31, 2008, as compared to Rs 125.7 crore for the quarter ended March 31, 2007. Total Income has increased 21 per cent from Rs 960.5 crore for the quarter ended March 31, 2007, to Rs 1162.7 crore for the quarter ended March 31, 2008.
 
Mon, 28 Apr 2008 12:58:58 GMT


Gulf Times

Indian stock index falls 0.6 percent on declines in Tata Steel, Cipla
International Herald Tribune, France - Apr 28, 2008
Pharmaceutical company Cipla Ltd. was among the biggest losers, down 4 percent to 215 rupees, followed by Tata Steel Ltd. 3.2 percent to 778 rupees and ...
Canara, Cipla, Essar Oil, ICICI, Pantaloon: India Stock Preview Bloomberg
DLF, Hindalco, Jaiprakash, Maruti, TVS: India Stock Preview Bloomberg
all 80 news articles
Mon, 05 May 2008 17:01:13 GMT


Cipla denies pitching Tarceva variant for unapproved cancers
Livemint, India - May 5, 2008
New Delhi / Mumbai: Mumbai-based drug maker Cipla Ltd has denied a charge that it has been promoting cancer drug erlotinib for four types of cancers when it ...
Fri, 25 Apr 2008 12:54:14 GMT


Cipla Profit Rises on Higher Overseas Sales of Drugs (Update1)
Bloomberg - Apr 25, 2008
By Mrinalini Datta April 25 (Bloomberg) -- Cipla Ltd., India's third-biggest drugmaker by market value, said fourth-quarter profit rose 42 percent, ...
India's Cipla FY net profit 7 bln rupees vs 6.68 bln Forbes
all 7 news articles
Sun, 04 May 2008 16:34:55 GMT


Sensex firms see worst profit growth in 2 yrs
Hindustan Times, India - May 4, 2008
Drug makers Ranbaxy Laboratories Ltd and Cipla Ltd, saw different trends in profit growth. While Ranbaxy’s profits were down 69.6 per cent , Cipla saw 42 ...
Indian shares close lower amid choppy trade; Wipro top loser Forbes
all 83 news articles
Fri, 25 Apr 2008 18:02:47 GMT


Robust sales drive Cipla Q4 net up 43%
Hindu Business Line, India - Apr 25, 2008
Mumbai, April 25 Cipla Ltd has posted a 43 per cent growth in net profit for the three months ended March 31, 2008, on the back of robust exports and ...
Cipla Q4 net jumps 42.8% yoy Business Standard
all 3 news articles
Fri, 18 Apr 2008 18:46:34 GMT


Roche distributor accuses Cipla of falsely promoting cancer drug
Livemint, India - Apr 18, 2008
The Drug Controller General of India has sought an explanation from Cipla Ltd after a distributor for rival Roche Scientific Co. (India) Pvt. Ltd raised an ...
Tue, 22 Apr 2008 17:47:07 GMT


Court to Cipla: one generic copy can be allowed in India
Livemint, India - Apr 22, 2008
A division bench of the Delhi high court on Tuesday upheld an earlier ruling that allowed India’s generic drug maker Cipla Ltd to manufacture and market a ...
 
Directory | Disclaimer
 
Developed by WorldITLab.
 
Copyright © 2004 - 2007 indianstockmarket.net . All rights reserved worldwide.
 
Content by Stock Market Guide